nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—PTGER4—cardiovascular system—attention deficit hyperactivity disorder	0.0249	0.236	CbGeAlD
Misoprostol—PTGER4—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.022	0.0246	CbGpPWpGaD
Misoprostol—PTGER2—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.0181	0.0202	CbGpPWpGaD
Misoprostol—PTGER4—nervous system—attention deficit hyperactivity disorder	0.016	0.152	CbGeAlD
Misoprostol—PTGER4—central nervous system—attention deficit hyperactivity disorder	0.0154	0.146	CbGeAlD
Misoprostol—PTGER3—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0152	0.017	CbGpPWpGaD
Misoprostol—PTGER3—nervous system—attention deficit hyperactivity disorder	0.0135	0.128	CbGeAlD
Misoprostol—PTGER3—central nervous system—attention deficit hyperactivity disorder	0.013	0.124	CbGeAlD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0125	0.014	CbGpPWpGaD
Misoprostol—PTGER4—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.0124	0.0139	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0123	0.0137	CbGpPWpGaD
Misoprostol—PTGER4—brain—attention deficit hyperactivity disorder	0.0122	0.116	CbGeAlD
Misoprostol—PTGER4—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0122	0.0136	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0107	0.012	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0105	0.0117	CbGpPWpGaD
Misoprostol—PTGER3—brain—attention deficit hyperactivity disorder	0.0103	0.0982	CbGeAlD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0103	0.0115	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.0102	0.0114	CbGpPWpGaD
Misoprostol—PTGER2—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.0102	0.0114	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0101	0.0113	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00999	0.0112	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00948	0.0106	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00929	0.0104	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00922	0.0103	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0088	0.00984	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00862	0.00964	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0085	0.0095	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00816	0.00912	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00812	0.00908	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.008	0.00894	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00796	0.0089	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00743	0.0083	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00728	0.00814	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00698	0.0078	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00694	0.00776	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0069	0.00772	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00688	0.00769	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0067	0.00749	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00669	0.00747	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00657	0.00735	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00657	0.00734	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00649	0.00726	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00644	0.0072	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00636	0.00711	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00625	0.00698	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00619	0.00691	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.0061	0.00682	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00606	0.00678	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00606	0.00677	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00605	0.00676	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00598	0.00668	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00592	0.00661	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00573	0.0064	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00567	0.00634	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00565	0.00631	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00563	0.00629	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00563	0.00629	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00556	0.00622	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00554	0.0062	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00552	0.00617	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00549	0.00614	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00546	0.0061	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.0054	0.00603	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00537	0.006	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00533	0.00596	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.0053	0.00593	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00523	0.00585	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00523	0.00584	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00521	0.00583	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00518	0.00579	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00513	0.00573	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00507	0.00566	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00498	0.00557	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00497	0.00555	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00494	0.00552	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00492	0.0055	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00486	0.00543	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00485	0.00542	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00482	0.00539	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00473	0.00529	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.0047	0.00526	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00462	0.00517	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00461	0.00516	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00458	0.00512	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00457	0.0051	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00455	0.00509	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00452	0.00505	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0045	0.00503	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00448	0.00501	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00436	0.00488	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00434	0.00485	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00429	0.00479	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00427	0.00477	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00425	0.00476	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00424	0.00473	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00424	0.00473	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00421	0.00471	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.0042	0.0047	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00419	0.00468	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0041	0.00459	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00398	0.00445	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00395	0.00441	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00393	0.00439	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00379	0.00423	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00371	0.00415	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0037	0.00413	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00369	0.00412	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00367	0.0041	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00363	0.00406	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00358	0.004	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00352	0.00394	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0035	0.00391	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00348	0.00389	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00348	0.00389	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00344	0.00385	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00343	0.00383	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00341	0.00382	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00337	0.00377	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00331	0.0037	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00325	0.00363	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00324	0.00362	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00321	0.00359	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00321	0.00359	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00317	0.00355	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00313	0.0035	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00311	0.00348	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00303	0.00339	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00299	0.00334	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00298	0.00333	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00288	0.00322	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00284	0.00318	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.0028	0.00313	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00276	0.00309	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00275	0.00307	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00274	0.00306	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00257	0.00288	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00255	0.00285	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00249	0.00278	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00247	0.00277	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00247	0.00276	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00242	0.00271	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00242	0.00271	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00239	0.00268	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00238	0.00266	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00237	0.00265	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00237	0.00264	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00234	0.00261	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00231	0.00258	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00227	0.00254	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00225	0.00251	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00224	0.0025	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00223	0.00249	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.0022	0.00246	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00218	0.00244	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00217	0.00243	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00216	0.00241	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00209	0.00234	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00209	0.00234	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00208	0.00232	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00204	0.00228	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00203	0.00227	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00202	0.00226	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00202	0.00226	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00199	0.00223	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00199	0.00222	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00197	0.0022	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00195	0.00218	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00193	0.00216	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.0019	0.00212	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00188	0.00211	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00188	0.0021	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00187	0.00209	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00184	0.00205	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00184	0.00205	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00184	0.00205	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00183	0.00205	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00181	0.00203	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00181	0.00202	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.0018	0.00201	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00178	0.00199	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00175	0.00196	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.0017	0.0019	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00169	0.00189	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00168	0.00188	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00167	0.00186	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00166	0.00186	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00165	0.00184	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00156	0.00175	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00153	0.00172	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00147	0.00164	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00142	0.00159	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00138	0.00154	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00137	0.00153	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00132	0.00148	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.0013	0.00145	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00128	0.00144	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00128	0.00143	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00127	0.00142	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00121	0.00135	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.0012	0.00134	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00118	0.00132	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00116	0.0013	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00112	0.00125	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00111	0.00124	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00109	0.00121	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00107	0.0012	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00107	0.00119	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00105	0.00118	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00103	0.00116	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.001	0.00112	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000985	0.0011	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000982	0.0011	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000973	0.00109	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000906	0.00101	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000838	0.000936	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000688	0.000769	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000635	0.00071	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000444	0.000496	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000364	0.000407	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000336	0.000376	CbGpPWpGaD
